Traws Pharma, Inc. Severance Costs
Traws Pharma, Inc. (TRAW) reported Severance Costs of $1.21 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-21.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2022-03-21
- Traws Pharma, Inc. severance costs for the quarter ending 2019-03-31 was $1.84M.
- Traws Pharma, Inc. severance costs for fiscal 2021 was $1.21M.
| Period end | Severance Costs 3 month | Severance Costs 12 month |
|---|---|---|
| 2021-12-31 | $1.21M 10-K · filed 2022-03-21 | |
| 2020-12-31 | $1.21M 10-Q · filed 2021-11-15 | |
| 2019-03-31 | $1.84M 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |